Proscia
Invested in 2020
07/2014
Company founded
11/2020
Scale leads $23M Series B
Digitizing and reinventing the 150-year-old standard for pathology. Proscia’s Concentriq digital pathology platform and pipeline of AI-powered applications let laboratories leverage new kinds of data to accelerate discoveries and improve patient outcomes.
Digitization has swept through almost every domain of healthcare, and we are now seeing its revolutionary impact on pathology.
Related resources
Scale team
Alex Niehenke
Partner
Jeremy Kaufmann
Partner